Kate Morgan is Co-CEO at Myeloma Patients Europe (MPE).

She has nearly 15 years in patient advocacy, with a particular focus on health policy and access. Prior to joining MPE, she led the Policy Team at Myeloma UK, where she influenced a range of policy, HTA and reimbursement decisions affecting patient access to treatment and care. Kate has been involved in a range of patient organisation and stakeholder networks, both nationally and internationally – including the Scottish Medicines Consortium Public Involvement Network Advisory Group and most recently the HTAi Interest Group for Patient and Citizen Involvement in HTA (PCIG) steering committee.

Katie Joyner is Co-CEO at Myeloma Patients Europe (MPE).

Katie holds a Bachelor of Arts in Journalism and Mass Communication from the University of North Carolina at Chapel Hill and a Master of Arts from Georgetown University in Liberal Studies with a concentration in International Affairs. Katie has 15 years of experience with non-profit organizations and higher education institutions. Prior to joining MPE, Katie served as the Director of Development at a large New York City non-profit supporting individuals with developmental disabilities where she oversaw fundraising, grant writing, Board relations, and special events. Katie is originally from North Carolina, United States and is currently based in Munich, Germany.

Monica is Access and Policy Manager at Myeloma Patients Europe (MPE).

Monica holds a PhD in Global Social Sciences from Doshisha University, Japan and a Master of Engineering in Applied Chemistry and Biotechnology from Nagoya University, Japan. For her bachelor’s degree she studied Biomedical Engineering at the University of Pharmacy and Medicine in Iasi, Romania. After her PhD she worked on science and health policy issues in academia, international development or consultancy in Italy, Austria and the UK. Subjects included cancer policy, healthcare workforce shortages, biosafety evaluations of genetically modified crops, Responsible Research and Innovation, and the use of Artificial Intelligence and the Internet of Things in health. A desire to work for non-profit organizations, in particular for one representing patients, led her to MPE, which she joined in January 2024.